Personalised Risk Prediction in Hereditary Breast and Ovarian Cancer: A Protocol for a Multi-Centre Randomised Controlled Trial
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Personalised Risk Prediction in Hereditary Breast and Ovarian Cancer: A Protocol for a Multi-Centre Randomised Controlled Trial
Authors
Keywords
-
Journal
Cancers
Volume 14, Issue 11, Pages 2716
Publisher
MDPI AG
Online
2022-05-31
DOI
10.3390/cancers14112716
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers: an international cohort study
- (2021) Lieske H. SCHRIJVER et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Uptake of bilateral-risk-reducing-mastectomy: Prospective analysis of 7195 women at high-risk of breast cancer
- (2021) D.Gareth Evans et al. BREAST
- Comprehensive epithelial tubo-ovarian cancer risk prediction model incorporating genetic and epidemiological risk factors
- (2021) Andrew Lee et al. JOURNAL OF MEDICAL GENETICS
- Responsible use of polygenic risk scores in the clinic: potential benefits, risks and gaps
- (2021) et al. NATURE MEDICINE
- Knowledge of potential harms and benefits of tamoxifen among women considering breast cancer preventive therapy
- (2020) Rachael Jane Thorneloe et al. Cancer Prevention Research
- Evaluating clinician acceptability of the prototype CanRisk tool for predicting risk of breast and ovarian cancer: A multi-methods study
- (2020) Stephanie Archer et al. PLoS One
- Polygenic risk scores: from research tools to clinical instruments
- (2020) Cathryn M. Lewis et al. Genome Medicine
- Validation of the BOADICEA model and a 313-variant polygenic risk score for breast cancer risk prediction in a Dutch prospective cohort
- (2020) Inge M. M. Lakeman et al. GENETICS IN MEDICINE
- The Emerging Field of Polygenic Risk Scores and Perspective for Use in Clinical Care
- (2020) Tatiane Yanes et al. HUMAN MOLECULAR GENETICS
- Association of a Polygenic Risk Score With Breast Cancer Among Women Carriers of High- and Moderate-Risk Breast Cancer Genes
- (2020) Shannon Gallagher et al. JAMA Network Open
- BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors
- (2019) Andrew Lee et al. GENETICS IN MEDICINE
- Do cancer risk and benefit–harm ratios influence women’s consideration of risk-reducing mastectomy? A scenario-based experiment in five European countries
- (2019) Felix G. Rebitschek et al. PLoS One
- Beyond interviews and focus groups: a framework for integrating innovative qualitative methods into randomised controlled trials of complex public health interventions
- (2019) Katy Davis et al. Trials
- Use of anastrozole for breast cancer prevention (IBIS-II): long-term results of a randomised controlled trial
- (2019) Jack Cuzick et al. LANCET
- Risk-Reducing Mastectomy in BRCA1 and BRCA2 Mutation Carriers
- (2018) Susan M. Domchek JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers
- (2017) Karoline B. Kuchenbaecker et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers
- (2017) Karoline B Kuchenbaecker et al. JNCI-Journal of the National Cancer Institute
- Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers
- (2017) Karoline B Kuchenbaecker et al. JNCI-Journal of the National Cancer Institute
- The Role of Risk-Reducing Surgery in Hereditary Breast and Ovarian Cancer
- (2016) Lynn C. Hartmann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Modifiers of Cancer Risk in BRCA1 and BRCA2 Mutation Carriers: A Systematic Review and Meta-Analysis
- (2014) Tara M. Friebel et al. JNCI-Journal of the National Cancer Institute
- What can qualitative research do for randomised controlled trials? A systematic mapping review
- (2013) A O'Cathain et al. BMJ Open
- Reasons for risk-reducing mastectomy versus MRI-screening in a cohort of women at high hereditary risk of breast cancer
- (2011) Iman Haroun et al. BREAST
- Oral contraceptive use and breast or ovarian cancer risk in BRCA1/2 carriers: A meta-analysis
- (2010) S. Iodice et al. EUROPEAN JOURNAL OF CANCER
- Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science
- (2009) Laura J Damschroder et al. Implementation Science
- Estimated Risk of Radiation-Induced Breast Cancer From Mammographic Screening for Young BRCA Mutation Carriers
- (2009) A. Berrington de Gonzalez et al. JNCI-Journal of the National Cancer Institute
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation